PainChek (PCK.AX) Stock Price
PainChek Price
Revenue has compounded at 123.1% per year over the past 11 years to 3.74 M AUD. PainChek's net margin stands at -238.8%, up from -584.6% several years earlier. Analysts set a median price target of 0.08 AUD, implying 12.3% below the current price. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
PainChek stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
PainChek business model & stock analysis
Frequently asked questions about PainChek
Analysts currently set an average price target of 0.08 AUD for the PainChek stock (median: 0.08 AUD), implying -12.3 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the PainChek stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the PainChek share trades at 0.06 EUR (0.09 AUD).
The revenue of PainChek is 3.74 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of PainChek is -8.94 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of PainChek is currently -2.18. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the PainChek stock.
The price-to-sales ratio (P/S) of PainChek is currently 5.19. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the PainChek stock.
The Eulerpool Quality Score for PainChek is 4/10.
The ISIN of PainChek is AU000000PCK6. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of PainChek is PCK.AX. The ticker symbol is used to trade PainChek shares on the stock exchange.
PainChek stock
PainChek Peer Group
PainChek FIGI
All fundamentals and in-depth analysis of PainChek
Our stock analysis for PainChek stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PainChek. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.